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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial pathogen resistance to antibiotics
including methicillin. The resistance first emerged in 1960 in a healthcare setting only after two years of using
methicillin as a viable treatment for methicillin-susceptible Staphylococcus aureus. MRSA leads to infections in
different parts of the body including the skin, bloodstream, lungs, or the urinary tract.
Methods: A deterministic model for methicillin-resistant Staphylococcus aureus (MRSA) with injection drug users is
designed. The model incorporates transmission of MRSA among non-injection drug users and injection drug users
(IDUs) who are both low-and high-risk users. A reduced MRSA transmission model with only non-IDUs is fitted to a
2008-2013 MRSA data from the Agency for Healthcare and Research and Quality (AHRQ). The parameter estimates
obtained are projected onto the parameters for the low-and high-risk IDUs subgroups using risk factors obtained by
constructing a risk assessment ethogram. Sensitivity analysis is carried out to determine parameters with the greatest
impact on the reproduction number using the reduced non-IDUs model. Change in risk associated behaviors was
studied using the full MRSA transmission model via the increase in risky behaviors and enrollment into rehabilitation
programs or clean needle exchange programs. Three control effectiveness levels determined from the sensitivity
analysis were used to study control of disease translation within the subgroups.
Results: The sensitivity analysis indicates that the transmission probability and recovery rates within the subgroup
have the highest impact on the reproduction number of the reduced non-IDU model. Change in risk associated
behaviors from non-IDUs to low-and high-risk IDUs lead to more MRSA cases among the subgroups. However, when
more IDUs enroll into rehabilitation programs or clean needle exchange programs, there was a reduction in the
number of MRSA cases in the community. Furthermore, MRSA burden within the subgroups can effectively be
curtailed in the community by implementing moderate- and high-effectiveness control strategies.
Conclusions: MRSA burden can be curtailed among and within non-injection drug users and both low-and high-risk
injection drug users by encouraging positive change in behaviors and by moderate- and high-effectiveness control
strategies that effectively targets the transmission probability and recovery rates within the subgroups in the
community.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
a bacterial pathogen resistance to antibiotics including
methicillin. It first emerged in 1960 in a healthcare setting
only after two years of methicillin being used as a viable
treatment for methicillin-susceptible Staphylococcus
aureus. MRSA has long been isolated in the community
since its emergence in the hospital setting.
Transmission of MRSA is achieved either by direct con-
tact with a colonized patient or indirect contact. Indirect
transmission occurs when the bacteria is transferred from
an infected person to a fomite where it can stay infectious
for months [1].
The epidemic of MRSA among injection drug users
(IDUs) began in 1981 and had since become endemic
in the community [2]. A number of research studies
have studied MRSA among IDUs by tracking registered
IDUs [3–6]. For instance, Fleisch et al. [5] followed 31
MRSA infected IDUs and found that 19 individuals devel-
oped secondary, life-threatening infections such as sep-
tic arthritis, endocarditis, pneumonia, and osteomyelitis.
Another study by Binswanger et al. [4] found that out
of a population of 169 IDUs, 29 individuals displayed
subcutaneous inflammation and infection.
Injection drug users present a unique set of behav-
ioral factors that all accumulate to an increased risk of
MRSA transmission and infection. One of those risk fac-
tors is trauma to the skin which creates opportunities for
MRSA bacteria to access their soft tissue during the act of
injecting their drug of choice. The proceeding factors all
vary depending on habits and behaviors associated with
injection drug use that will be detailed in the “Parameter
estimation” section.
Our goal was to understand the transmission dynamics
of MRSA in a community with IDUs and to investigate
the impact of drug rehabilitation programs, intervention,
education, clean needle exchange programs, and so forth
[7, 8] as part of control measures to curtail MRSA trans-
mission in the community. Therefore, we formulate a
deterministic model for MRSA transmission dynamics
which include non-IDUs and two subgroups of IDUs with
different risk associated behaviors (i.e., low- and high-risk
behaviors).
This paper is organized as follows: in “Model formulation”
section, we present the MRSA transmission model
and calculate the basic reproduction number. In the
“Parameter estimation” section, we estimate the values
of the model parameters. In the “Sensitivity analysis”
section, we carry out a sensitivity analysis to identify the
model’s parameters with the most impact on our response
function. Using the results obtained from the sensitivity
analysis, we investigate in “Control measures” section the




To formulate the methicillin-resistant Staphylococcus
aureus transmissionmodel with injection drug users, indi-
viduals in the community were divided into three sub-
groups, non-injection drug users (IDUs), low-risk IDUs,
and high-risk IDUs in order to understand the inter-
actions between these populations. Each subgroup was
subsequently divided into three compartments according
to their disease status. Thus, we have uncolonized sus-
ceptible individuals (Ui), colonized individuals (Ci), and
infected individuals (Ii), where i = N , L,H for non-IDUs,
low-risk IDUs, and high-risk IDUs. These premises lead
to the following total population
N = UN + CN + IN + UL + CL + IL + UH + CH + IH
The MRSA transmission dynamics with IDUs is given
by the following system of ordinary differential equations
and depicted in Fig. 1. The associated variables and
parameters are described in Table 1.
dUN
dt
= πN + αLUL + τNCN + γNIN





= αLCL + βN (CN + IN + CL + IL + CH + IH))N
−(τN + σN + ωN + μ)CN
dIN
dt
= αLIL + σNCN − (ωN + γN + μ + δN )IN
dUL
dt
= πL + ωNUN + αLUL
−βL(CN + IN + CL + IL + CH + IH)
N
+τLCL + γLIL − (ωL + αL + μ)UL
dCL
dt
= ωNCN + αHCH + βL(CN + IN + CL + IL + CH + IH)N
−(τL + ωL + αL + σL + μ)CL
dIL
dt
= ωNIN + αHIH + σLCL − (ωL + αL + γL + μ + δL)IL
dUH
dt
= πH + ωLUL + γHIH + τHCH





= ωLCL + βH(CN + IN + CL + IL + CH + IH)N
−(τH + αH + σH + μ)CH
dIH
dt
= ωLIL + σHCH − (αH + γH + μ + δH)IH . (1)
The parameter πN is the recruitment rate into the
uncolonized non-injection drug users (UN ) subgroup.
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Fig. 1 Flow diagram of the MRSA model (1) with IDUs
The parameter μ is the natural death rate in each sub-
population. The force of infection of the non-injection
drug users is given by
βN (CN + IN + CL + IL + CH + IH)
N
,
where βN is the probability of an uncolonized individ-
ual becoming colonized upon being exposed to MRSA
bacteria through contact with colonized or infected indi-
viduals in either the non-injection drug users class or the
low-risk class or the high-risk classes. Once individuals
in the colonized class are decolonized at the rate τN [9],
they move back to the uncolonized class. However, as the
Table 1 Variable and parameter descriptions for the MRSA
model (1) per day
Variable Description
UN ,UL ,UH Population of uncolonized non-IDUs, low-risk IDUs,
and high-risk IDUs
CN , CL , CH Population of colonized non-IDUs, low-risk IDUs,
and high-risk IDUs
IN , IL , IH Population of infected non-IDUs, low-risk IDUs,
and high-risk IDUs
Parameter Description
πN , πL , πH Natural birth rate
βN ,βL ,βH Transmission probability per contact with colonized
or infected population
σN , σL , σH Progression rate of colonized population
γN , γL , γH Recovery rate of infected population
τN , τL , τH Decolonization rate of colonized population
ωN ,ωL ,ωH Increased IDU risk behavior
αN ,αL ,αH Decreased IDU risk behavior
μ Natural death rate
δN , δL , δH Death rate due to disease
disease progresses, the colonized non-IDUs (CN ) move
to the infected class at rate σN . They recover at the rate
γN and thus move from the infected compartment (IN )
back to the uncolonized class (UN ). The parameters and
transitions for the low-risk and high-risk populations are
similarly defined (with the subscript N replaced by L and
H respectively).
If non-IDUs engage in risky behavior resulting from
injection drug use, we assume that this behavior initially
involves a less risky use of drugs and as such these indi-
viduals leave the non-IDUs subgroup at rate ωN into
the low-risk IDU subgroup. However, if these individuals
decrease their risky behaviors either by enrolling in drug
rehabilitation programs [3, 10] or by other kinds of inter-
ventions they move back into the non-IDU subgroup at
the rate αL.
Individuals in the low-risk subgroup who further engage
in increased risky behaviors move into a high-risk injec-
tion drug users subgroup at the rate ωL. As with the
low-risk individuals, these individuals may stop injecting
drugs when they enroll in a drug rehabilitation or nee-
dle exchange programs [3, 10].We assume these processes
are not instantaneous. Hence they first enter the low-risk
subgroup at rate αH . Injection drug users harbor more
S. aureus bacteria compare to non users [11], and required
prolonged treatment [12, 13], thus we assume that these
risky behaviors increases the rates of MRSA transmission
[14, 15].
The basic reproduction number
The basic reproduction number (R0) of the MRSA model
(1) with IDUs is given below; the theoretical study of the
model basic properties is stated in Appendix A under
‘Analysis of themodel’ and the calculations ofR0 are given
in Appendix B.
R0 = RN + RL + RH , (2)
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where
RN = βNU∗N [k7ωN (k3k8 + ωLk3 + k8αL)σL
+ (k6k8+ωNk8 + ωNωL − ωLαH)(k5k7 − ωLαH)σN
+ ωNωL(k3k6 + k3αH + αHαL − ωNαL)σH
+(k5k7 + k7ωN + ωLωN − ωLαH)(k3k6k8
−k3ωLαH − k8ωNαL)] /N∗(k3k6k8 − k3ωLαH
− k8ωNαL)(k2k5k7 − k2ωLαH − k7ωNαL)
RL = βLU∗L [k2k7(k3k8 + ωLk3 + αLk8)σL
+ k7αL(k6k8 + k8ωN + ωNωL − ωLαH)σN
+ k2ωL(k3k6 + k3αH + αLαH − ωNαL)σH
+(k2k7 + k2ωL + k7αL)(k3k6k8 − k3ωLαH
−k8ωNαL)] /N∗(k3k6k8 − k3ωLαH − k8ωNαL)
× (k2k5k7 − k2ωLαH − k7ωNαL)
RH = βHU∗H [αLαH(k6k8 + k8ωN + ωNωL − ωLαH)σN
+ k2αH(k3k8 + k3ωL + k8αL)σL
+ (k3k6 + k3αH + αLαH − ωNαL)(k2k5 − ωNαL)σH
+(k2k5 + k2αH + αLαH − ωNαL)(k3k8k6 − k8ωNαL
−k3ωLαH)] /N∗(k3k6k8 − k3ωLαH − k8ωNαL)
× (k2k5k7 − k2ωLαH − k7ωNαL).
Furthermore, the expression RN is the number of sec-
ondary infections among the non-injection drug users,RL
is the number of secondary infections among the low-
risk injection drug users, RH is the number of secondary
infections among the high-risk injection drug users. These
expressions (RN ,RL,RH ) include the secondary infec-
tion in each sub-groups due to both horizontal and ver-
tical transitions of infectious individuals due to disease
translation and risky behaviors within and between the
subgroups.
The basic reproduction number R0 is defined as the
average number of new infections that is produced as a
result of the introduction of one infectious individual into
a population that is fully susceptible [16–19].
The basic reproduction number when
ωN = ωL = αL = αH = 0
Suppose the vertical upward and downward transition
between the subgroups are absent, that is, ωN = 0, ωL =
0, αL = 0, αH = 0, then the basic reproduction number
of the MRSA model (1) with IDUs, is given as:




N (k3 + σN )
k2k3N∗










It should be noted that the reproduction number stated
in Eq. (2) gives the reproduction number in Eq. (3) in the
absence of vertical downward and upward transition, that
is, if ωN = ωL = αL = αH = 0.
Parameter estimation
MRSADemographic data from 2008-2013
Demographic data from 2008-2013 was obtained from
the Agency for Healthcare Research and Quality (AHRQ)
[20]. The AHRQ compiles international classification of
diseases (ICD) data from hospitals throughout the United
States. These data include patients who were discharged
with MRSA and are identified with ICD-9 code. To obtain
the MRSA ICD-9 data, AHRQ demographic data targets
were set to look at large metro, large suburb, and rural
areas. As expected, the large metro population produced
the highest number of patients with MRSA listed on their
medical records upon discharge. Figure 2 displays the
obtained data in tens of thousands of hospital discharges
from 2008-2013.
Non-IDU subgroup parameter estimation
In order to parametrize MRSA model (1) we use patient
data obtained from the AHRQ surveys. One of the limi-
tations of this data is that it does not identify individuals
with MRSA that are injection drug users. To overcome
this short coming, we first assume that the population
consist of only non-IDUs and then we reduce the MRSA




= πN + γNIN + τNCN − βN (CN + IN )N − μUN
dCN
dt
= βN (CN + IN ))
N
− (τN + σN + μ)CN
dIN
dt
= σNCN − (γN + μ + δN ) IN (5)
Fig. 2 Demographic data from three regional areas, large metro, large
suburb, and rural. Red dots represent large metro areas, magenta
correspond to the large suburb areas and turquoises blue represent
the data for rural areas
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For the reduced MRSA model (5) with non-IDUs, the
total population N = UN + CN + IN , and the force of
infection is given by βN (CN+IN )N . The basic reproduction
number is given as:
RN = βNU
∗
N (k3 + σN )
k2k3N∗
, (6)
where k1 = μ, k2 = τN + σN + μ, k3 = γN + μ + δN .
Next, we estimate the parameters of the reduced MRSA
model (5) by using the ICD-9 MRSA data for large metro,
rural, and suburb regional areas. The results of the param-
eter estimation are given in Table 2; the model simulation
profile and the fitted data are depicted in Fig. 3.
A number of studies have identified injection drug use
as a significant risk factor for developing MRSA sec-
ondary to hospitalization rates and increased exposure
to antibiotics arising from treatment of skin abscesses,
bacteremias, and endocarditis [12–14]. Cohen [21] estab-
lished a relationship between the use of metham-
phetamine and the occurrence of MRSA. Hence, we
assume that the relationship between injection drug use
and the risk of developingMRSA is linear. This enabled us
project the non-IDUs parameters onto the low- and high-
risk IDUs parameters using some risk related parameters
discussed below.
Therefore, in order to obtain the parameter estimates
for the IDUs in the full MRSA model (1), we modify the
transmission probability, disease progression and recov-
ery rates in the low- and high-risk subgroups by multiply-
ing the non-IDUs subgroup parameter estimates βN , σN ,
and γN with εL and εH . These parameters represent the
associated risky behaviors in low-risk and high-risk sub-
groups. The non-IDU disease induced mortality δN is also
modified by εL and εH , since IDUs have a higher mortality
rate due to their drug use [22–24].
These modification parameters εL and εH are called
risk factors; their values give us an estimate away (either
in an increasing or decreasing form) from the non-IDUs
parameters. How these parameter values are obtained for
the IDUs in the low-risk, and high-risk subgroups are
discussed below.
Table 2 Parameter estimation of the non-injection drug users
using the reduced MRSA model (5) and the regional data
obtained from the Agency for Healthcare Research and Quality
(AHRQ) [20]
Variable Large metro Rural Suburb
βN 0.2895 0.2015 0.1444
γN 0.2778 0.1874 0.1316
σN 0.7079 0.6670 0.6560
Risk factors εL and εH formulation
The risk factor is designed to distinguish the parameter
values in all the subgroups from one another. It incorpo-
rates qualitative characteristics of injection drug use in the
low-risk and high-risk subgroup transformed into quan-
titative integers that are used to impact the low-risk and
high-risk parameters described in the MRSA model (1)
formulation.
Hence, the low-risk IDU subgroup transmission proba-
bility (βL), disease progression rate (σL), recovery rate (γL),
and MRSA-induced death (δL) are all modified from the
non-injection drug users parameter values by a risk factor
(εL) associated with the risk-associated behaviors. Hence,
βL = βN (1 + εL), σL = σN (1 + εL),
γL = γN (1 − εL), δL = δN (1 + εL). (7)
The parameters βL and σL are both increased by the
introduction of a risk factor εL. This increases the rate at
which individuals move from the uncolonized class,UL, to
the colonized class, CL, and subsequently, to the infected
class, IL, compare to the individuals in the non-IDUs sub-
group. On the other hand, γL is decreased by the effect of
εL, thus decreasing recovery rate and holding individuals
in the infected compartment for a longer period compare
to non-IDUs.
The high-risk IDU subgroup parameters undergo an
analogous treatment but with a larger, and higher impact-
ing value εH in place of εL as shown in [6]. Thus,
βH = βN (1 + εH), σH = σN (1 + εH),
γH = γN (1 − εH), δH = δN (1 + εH). (8)
To estimate the values of the risk factors εL and εH ,
we first construct an ethogram. The practice of using
ethograms is common within the study of animal behavior
[25, 26]. This technique allows the researcher to quantify
behaviors observed in the subject(s) and their interac-
tion with other organism or with their environment. This
technique was used to construct Tables 3 and 4.
To construct Table 3, we classify individuals’ associ-
ated risk behavior from non-drug use to severe drug use,
assigning a value from 0-5 based on the perceived level of
risk. The ranking values in Table 3 is then translated to
the rating points in the complimentary Table 4 by sum-
ming the ranking values of an injection drug user from
their previous to current categories. For instance, a mod-
erate IDU has a rating point of 6; this comes from them
having been a limited to mild andmoderate drug user (i.e.,
0+1+2+3 = 6, obtained from ranking values in Table 3).
Thus, a severe IDU will have a ranking of 15 points (i.e.,
0 + 1 + 2 + 3 + 4 + 5 + 6 = 15).
Using these ranking points, we classify the individuals
into low-risk and high-risk IDUs (see Table 4). To obtain
the risk factor percentages, we use a ratio of 1 rating point
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Fig. 3 Simulation of the non-IDUs reduced MRSA model (5) fitted to the ICD-9 MRSA data for: (a) Large metro area data and model simulation;
(b) Large suburbs area data and model simulation; (c) Rural area data and model simulation. Turquoise solid lines represent model simulations, red
dot in (a) represent large metro area data, magenta dot in (b) is the data for large suburb area and the black dot in (c) is the data for rural area
to 6% risk factor value (1 rating = 6% risk factor); the
ratio of 1-6 is chosen since there are six risk categories
under consideration. Thus, we have 6-36% for a low-risk
IDU and a 42-90% high-risk IDUs thresholds. These rep-
resent the percentage that the non-IDU parameters will
be amplified by (βN , σN , δN ) or decreased by (γN ) due to
associated IDU risky behaviors.
Sensitivity analysis
In order to determine the robustness of the model in
relation to each parameter, a sensitivity analysis was per-
formed. Analysis of parameters can give insight into the
Table 3 Ethogram displaying and quantifying injection drug
users risk associated behaviors
Ranking Classification Definition
0 No drug use No use of injection drugs
1 Limited drug use Lone occasional use of injection drugs
2 Mild drug use Occasional use of injection drugs with
other users and visiting shooting galleries
3 Moderate drug use Sharing/ splitting drugs
4 Intense drug use Sharing/ splitting drug paraphernalia
5 Severe drug use Occupying a shooting gallery full time
uncertainty an input may have and how this will affect the
outcome of the model. To determine system sensitivity to
its parameters, the normalized forward sensitivity index




× pRN , (9)
where p represent the parameter of interest and RN , the
reproduction number RN of the reduce model (5); since
the parameters of MRSA model (1) were obtained from
fitting to data the reduced model (5) and modifying their
values using the risk factors εL and εH to obtain the
values for the IDUs parameters. Hence, the local sensitiv-
ity analysis was performed on the following parameters:
the transmission probability (βL), disease progression rate
(σL), recovery rate (γL), MRSA-induced death (δL), and
natural death (μ) based on their influence onRN .
Table 4 Ethogram complementary table displaying and
quantifying injection drug user risk associated behaviors
Rating Class assignment Risk factor (%)
0 Non-injection drug user 0
1-6 Low-risk injection drug user 6-36
7-15 High-risk injection drug user 42-90
Wagner and Agusto BMC Infectious Diseases  (2018) 18:69 Page 7 of 18
Control measures
The best strategy to preventing MRSA infections among
IDUs would be for them to end their risky behaviors, many
of these IDUs are not ready to stop or make a change
in their behaviors [30]. However, by simply learning new
hygiene skills or best practices may substantially decrease
the risk of MRSA among individuals who are reluc-
tant to stop injecting drugs [30, 31]. For instance, Hart
et al. observed a reduction in the incidence of abscesses
among IDUs registered in a needle exchange program
in London.
In this section we considered two types of control strate-
gies; the first strategy investigates the impact of vertical
downward transition between the subgroups due to indi-
viduals in the community engaging in risky behaviors
that promote injection drug use and the impact of verti-
cal upward transition that can be achieved by enrolling
in rehabilitation programs. The aim of this strategy is to
investigate the impact of the parameters ωN and ωL, for
the vertical downward transition and the parameters αL
and αH for the vertical upward transition.
The second strategy uses results obtain from the sensi-
tivity analysis to consider control within each subgroup.
With this strategy, we target the parameters βN and
γN by implementing three different control strategies:
low-effectiveness strategy, moderate-effectiveness strat-
egy, and high-effectiveness strategy. The goal of each
strategy is to reduce βN and increase γN . The risk fac-
tors εL and εH are then used to determine the values
of βL, βH , γL and γH in the low-and high-risk IDUs
subgroups respectively.
Note that for the two different control strategies either
between or within the subgroups, we used the intermedi-
ate risk factor values εL = 21% and εH = 66 %.
Control of risky injection drug use behaviors
In this section, we investigate the impact of vertical down-
ward and upward transitions between the compartments
due to risky behaviors that promotes (downward transi-
tions) and discourages (upward transitions) injection drug
use in the community. The aim of this control strategy is
to investigate the impact of vertical downward transition
using the parameters ωN and ωL, and impact of the ver-
tical upward transition using the parameters αL and αH .
Note in this section we are controlling the risky behaviors
and not MRSA transmission within the subgroups.
No vertical downward and upward transitions
First, suppose that there are no transition between the
subgroups (i.e., non-IDUs, low-risk IDUs and high-risk
IDUs); in other words, there are no vertical downward
transitions due to risky behaviors nor are there verti-
cal upward transitions due to enrollment in rehabilitation
programs, that is ωN = 0,ωL = 0,αL = 0,αH = 0.
Vertical downward transitions only
Next, we consider the situation with only vertical down-
ward transitions and no upward transitions. Suppose indi-
viduals in the non-IDUs slowly engage in the risky behav-
ior of injection drug use, but individuals in the low-risk
IDUs quickly engage in these risky behaviors either due
to peer pressure or due to individuals physiology [32, 33].
Thus, we set ωN = 0.05825,ωL = 0.116,αL = 0,αH = 0.
Vertical upward transitions only
Next, we investigate the impact of the vertical upward
transitions that can be achieved by enrolling in rehabil-
itation programs [3, 6]. Suppose more individuals in the
high-risk IDUs enter rehabilitation programs either due
to referrals from those around them or due to increased
access to such programs [34] or through family interven-
tions [35]. Further, suppose fewer low-risk IDUs enter
rehabilitation program because they either do not see the
need for the program or they believe they could han-
dle the problem without the rehabilitation program or
they believe in their ability to control their risky behav-
iors [36]. For this scenario, we set ωN = 0,ωL = 0,αL =
0.0112,αH = 0.0560.
Vertical downward and upward transitions
Lastly, we investigate the impact of both downward and
upward transitions due to changes in risky behaviors; that
is, we set ωN = 0.05825,ωL = 0.116,αL = 0.0112,αH =
0.0560.
Control of MRSA transmission among the sub-groups
According to the Centers for Disease Control and Pre-
vention (CDC), maintaining adequate personal hygiene
is vital for the control of MRSA in the community [37].
In hospital setting, health-care workers are required to
constantly clean their clothing, laundry, medical equip-
ment and the entire hospital environment to prevent and
minimize contact and transmission of the bacteria [37].
In this section, we investigate the impact of control-
ling MRSA transmission within the subgroups, we will
not consider decolonization as a control strategy. Thus,
to determine the impact of controlling MRSA within the
subgroups, we use results obtained from the sensitivity
analysis. From the sensitivity analysis, we observed that
control strategies that reduce βN and increases γN would
impact MRSA in the community since these parame-
ters have strong positive (βN ) and negative (γN ) impact
on the reproduction number RN . The same holds for
the parameters βL,βH , γL, and γH . Hence, we imple-
ment three different strategies: low-effectiveness strategy,
moderate-effectiveness strategy, and high-effectiveness
strategy. Note that these strategies are only for theo-
retical purpose to illustrate the impact of these control
interventions.
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Low-effectiveness control strategy
Our aim in this section is to investigate the control strate-
gies that reduces MRSA transmission in the community.
To achieve this in both the non-IDUs and IDUs popula-
tions, we assumed that the IDUs do not forfeit any of their
risk associated behaviors. And they also do not alter their
medical circumstances by actively seeking out medical
treatment.
Thus, for this low-effective strategy, we set βN =
0.27780 and γN = 0.27780 (the values obtained from the
data fitting above). Using the modifying risk factors εL
and εH , we obtain the values for βL, γL,βH and γH respec-
tively. That is, βL = βN (1 + εL),βH = βN (1 + εH), γL =
γN (1 − εL), and γH = γN (1 − εH).
Moderate-effectiveness control strategy
We reiterate that unlike in the previous section, our aim
in this section is not to control the risky behavior but to
control the transmission of MRSA within the subgroups.
Thus, to implement the moderate-effectiveness control
strategy, we assume that if an IDU ceases to share their
drug paraphernalia with other IDUs [6], this will reduce
the physical contact with other IDUs which invariably
reduces the transmission probabilities βN , βL, and βH .
Hence, for the moderate-effectiveness control strategy
we set
βN = βN/2, γN = (1 + 0.007)γN
βL = βN (1 + εL), βH = βN (1 + εH)
γL = γN (1 − εL), γH = γN (1 − εH).
Note that recovery rate (γN ) in the non-IDUs have been
increased by 0.7%.
High-effectiveness control strategy
We assume that the IDUs in the community enroll in
a drug abuse program (DAP) [3, 6]. Note that the vol-
untary or involuntary enrollment into a DAP will not
stop the use of injection drugs, but it will significantly
decrease the practice of risk-associated behaviors. Edu-
cation and accountability given to individuals enrolled in
the DAP will effectively reduce the risk-associated behav-
iors listed in Table 3 and by extension will lead to a
reduction in the disease transmission probabilities βN , βL,
and βH [5, 6].
Additional benefits gained by the IDUs who participate
in the program include access to medical professionals
and to resources such as symptom and treatment educa-
tion. These benefits can empower MRSA infected IDUs
with tools necessary to recognize and treat their infec-
tions. Bassetti et al. found that the addition ofmedical care
to MRSA infected IDU patients significantly reduced the
use of drugs [3]. As explained in [3], a major benefit of
DAPs is access to quality health care. Such access will not
only provide a better understanding of disease transmis-
sion and hygiene techniques but will also provide timely
diagnosis and a more precise consumption of medicine.
This improved access to health care invariably leads to
increase in the recovery rate of the IDUs, that is, increase
in γL and γH .
Thus, for the high-effectiveness control strategy we set
βN = βN/4, γN = (1 + 0.009)γN
βL = βN (1 + εL), βH = βN (1 + εH)
γL = γN (1 − εL), γH = γN (1 − εH).
In this case, the recovery rate (γN ) in the non-IDUs have
been increased by 0.9%.
Results
In this paper, we have designed and studied a determinis-
tic model for methicillin-resistant Staphylococcus aureus
(MRSA) transmission in the community with injection
drug users (IDUs). Unique to our model is the incorpo-
ration of two IDUs with low- and high-risk associated
behaviors. Our goal in this paper is to understand the
transmission dynamics of MRSA in a community with
IDUs and to investigate the impact of different con-
trol strategies in curtailing MRSA transmission in the
community. Thus, the intervention strategies analyzed
include the impact of drug rehabilitation, intervention
and education, and clean needle exchange programs on
MRSA transmission in the community (i.e., the verti-
cal upward and downward transition) as well as three
control effectiveness strategies at each subgroup levels
(i.e., low-effectiveness, moderate-effectiveness, and high-
effectiveness strategies).
The model theoretical results indicate that the disease-
free equilibrium of the model is locally-asymptotically
stable whenever the related reproduction number is less
than unity and stable otherwise. The implication of this
result is that the disease will die out or be curtailed when-
ever the reproduction number is less than unity and will
spread whenever the reproduction is greater than unity.
Parameter estimation
We parameterized the model using the 2008-2013 Agency
for Healthcare Research and Quality (AHRQ) data-set;
these data include patients who were discharged with
MRSA. A major limitation with the use of this data-set is
that it includes individuals who may have acquired MRSA
infection due to their hospital stay. As a result, the data-
set does not truly capture the transmission of the bacteria
in the community which is more appropriate for evaluat-
ing MRSA burden amongst IDUs in the community. To
overcome this limitation, we assumed that the population
consist of only non-IDUs and reduce theMRSAmodel (1).
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This enabled us determine parameters that are pro-
jected onto the low and high risk-IDUs using risk factors
εL and εH .
Having obtained the estimate for the risk factors εL and
εH , we investigated the impact of varying these modifica-
tion parameters on disease transmission in the commu-
nity. For the low-risk factor εL, we used the lower and
upper bound values (6% and 36%) given in Table 4 and
their intermediate value (21%). Similarly, for the high-risk
factor, we used 42%, 66%, and 90%.
Figure 4 depict the results of simulating the full MRSA
model (1) using the parameter estimates given in Table 2
and the low, intermediate, and high bounds of the risk fac-
tors εL and εH in Table 4. At the lower bounds of the risk
factors (εL = 6% and εH = 42%), the non-IDUs have the
highest number of colonized individuals, this is followed
by low-risk IDUs, while the high-risk IDUs have the least
number of colonized individuals (not shown here in the
figure). Within the infected compartment, the high-risk
IDUs have the highest number of individuals followed by
the low-risk then non-IDUs. The disparity between each
subclass increases when the risk factor is increased such
as the high-risk IDUs with a greater number of infected
compared to the low-risk and non-IDUs.
A similar trend is observed in Fig. 5 for the suburb
and rural regional areas using intermediate risk factors
estimates εL = 21% and εH = 66%.
For the rest of the paper, we will use the parameter
estimates for the large metro area since the number of
patients in the ICD-9 data for this area is the largest;
moreover, the results for the large suburb and rural areas
are not expected to deviate from the results obtained for
large metro areas.
Sensitivity analysis
The outcome of the local sensitivity analysis using param-
eters estimated in Table 2 is shown in Table 5; the
parameter βN and γN are both shown to have the largest
impact on the reproduction number (RN ). The implica-
tion of this result is that any control strategy which target
these two parameters will give the greatest impact onRN .
For instance a control strategy that decreases βN by 10%
will lead to a 10% reduction in RN , similarly, a strategy
that increases γN by 10% will lead to a 7.2% decrease in
RN . In the next section, we addressed control measures
that targets βN and γN with the goal of reducingRN .
Control measures
We investigated the impact of the different control strate-
gies to curtail MRSA transmission within and between
each subgroup in the community by first controlling the
risky behaviors within the groups and secondly by con-
trolling the transmission of the bacteria among the groups
using parameter values given in Tables 6 and 7.
Fig. 4 Simulation of the MRSA model (1) with varied risk factors εL and εH values. a Infected individuals with 6% lrf and 42% hrf. b Infected
individuals with 21% lrf and 66% hrf. c Infected individuals with 36% lrf and 90% hrf. Parameter values used are as given in Tables 6 and 7. Blue lines
correspond to non-IDUs, green represent the low-risk IDUs and red represent the high-risk IDUs
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Fig. 5 Simulation of the MRSA model using regional data with 21% low-risk factor and 66% high-risk factor. a Infected individuals in suburb area.
b Infected individuals in rural area. Parameter values used are as given in Tables 6 and 7. Blue lines correspond to non-IDUs, green represent the
low-risk IDUs and red represent the high-risk IDUs
Control of risky injection drug use behaviors
Under this control strategy, we consider four scenarios
involving transitions between the groups.
No vertical downward and upward transitions
We observed in Fig. 6a that the non-IDUs have more col-
onized individuals followed by the low-risk IDUs and the
high-risk IDUs have the least number of colonized indi-
viduals. These dynamics is due to the fact that disease pro-
gression rate is highest in the high-risk IDUs and smallest
in the non-IDUs. This explains the result of Fig. 6b where
the high-IDUs have themost number of infected individu-
als followed by the low-risk IDUs, and the non-IDUs have
the least number of infected individuals.
Vertical downward transitions only
We observed in Fig. 7 an increase in the number of colo-
nized and infected high-risk individuals and a decrease in
the colonized and infected compartments of the other two
subgroups. The result of this simulation can be thought
of as a funnel that sifts individuals down through the
model into more risky behaviors and thus an increase in
transmission of MRSA for the high-risk IDUs.
Vertical upward transitions only
We observed more colonized individuals in the non-IDUs
subgroup in Fig. 8a, followed by the low-risk IDUs and
Table 5 Sensitivity Index using parameter estimates obtained







The result shows that βN and γN have the greatest impact on the output value of
RN
the high-risk IDUs have the least number of colonized
individuals. However, in the infected compartment (see
Fig. 8b) the low-risk IDUs have more individuals for about
55 days due to the surge from the high-risk individuals
changing their behavior. But over time, the non-IDUs have
more infected individuals as individuals move upwards
between the subgroups.
Vertical downward and upward transitions
We observed in Fig. 9 similar effect as seen in Fig. 7 but in
this case, fewer non-IDUs individuals were colonized and
infected; this is due to the transitions to the other two sub-
groups. Thus, there are more individuals in the colonized
and infected compartments in the high-risk, and low-risk
IDUs subgroups in Fig. 9 compare to those in Fig. 7.
Hence, we have explored in this section the impact
of the vertical downward and upward transitions among
non-injection drug users and injection drug users who
are both low-and high-risk users due to change in risky
Table 6 Parameter values and ranges for MRSA model (1) with
IDUs












μ 0.00824 [52, 53]
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Table 7 Parameter values and ranges for MRSA model (1) with
IDUs using the risk factors εL and εH ranges given in Table 4
Variable Baseline value Range References
βL 0.30500 (0.30687-0.39372) Estimated
βH 0.48060 (0.41109-0.55002) Estimated
σL 0.85656 (0.75047-0.96274) Estimated
σH 1.17511 (1.00522-1.34501) Estimated
γL 0.21946 (0.26113-0.17779) Estimated
γH 0.09445 (0.16110-0.02778) Estimated
εL 0.21000 (0.06000-0.36000) Estimated
εH 0.66000 (0.42000-0.90000) Estimated
δN 0.00033 (0.48060-0.55010) [53]
δL 0.00040 (0.00035-0.000045) Estimated
δH 0.00047 (0.00055-0.00063) Estimated
behaviors and found that as individual engage in these
risky behaviors, MRSA cases in the community increase.
However, with more IDUs enrolling into rehabilitation,
intervention, and education, and clean needle exchange
programs MRSA cases reduces in the community. This
control is intended to simulate the decline in risky behav-
ior which could be achieved by rehabilitation programs,
intervention and education, clean needle exchange pro-
grams, and so forth [7, 8].
Control of MRSA transmission among the sub-groups
The result of the sensitivity analysis was used to study the
horizontal translation within the subgroups due to disease
transmission by implementing three different strategies:
low-effectiveness strategy, moderate-effectiveness strat-
egy, and high-effectiveness strategy with the goal of reduc-
ing the number of colonized and infected individuals.
The total number of colonized and infected individu-
als in each of the different subgroups is simulated for
the three levels of effectiveness for the low-effectiveness,
moderate-effectiveness, and high-effectiveness control
strategy and depicted in Fig. 10 are the solution profiles
for the infected.
Figure 10 shows a reduction in each of the subgroups
under the moderate- and high-effectiveness levels of
the control strategy. It is worth noting that the high-
effectiveness level of the control strategy, as expected, is
far more effective in curtailing MRSA burden in the com-
munity. The moderate-effectiveness level of the strategy
also resulted in a significant decline in the number of cases
in comparison to the low-effectiveness level of the control
strategy.
Specifically, the comparison of the three effectiveness
strategies at t = 100 days in each of the different sub-
groups (see Table 8), shows that the high-effectiveness
control strategy led to a considerable reduction in the
total number of colonized and infected individuals. This is
followed by the moderate-effectiveness level, and the low-
effectiveness level which produced the most number of
colonized and infected cases.
Thus, in this section, we found that the high-
effectiveness control strategy is more effective in
curtailing MRSA burden in the community, this is fol-
lowed by the moderate-effectiveness strategy, and the
low-effectiveness strategy performed the least; further-
more, we found that the moderate-effectiveness strategy
is also an effective control strategy.
These simulations clearly shows that MRSA is con-
trollable in a community with IDUs using the control
measures, such as the moderate- and high-effectiveness
levels of the control strategy described above.
Discussion
MRSA nasal carriage is shown to be in 33% of the pop-
ulation in the United States [38]. This high number of
carriers have the potential to infect individuals they come
into physical contact or share intimate materials with [39].
In communities of people in close contact such as inmates
Fig. 6MRSA model simulation with large metro demographics. Each simulation shows a restriction of individuals transition between sub-groups
with the parameter values ωN = 0,ωL = 0,αL = 0,αH = 0 (a) Colonized individuals, (b) Infected individuals. Parameter values used are as given in
Tables 6 and 7. Blue lines correspond to non-IDUs, green represent the low-risk IDUs and red represent the high-risk IDUs
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Fig. 7MRSA model simulation with large metro demographics. Each simulation shows a restriction of individuals transition between sub-groups
with the parameter values ωN = 0.05825,ωL = 0.116,αL = 0,αH = 0 (a) Colonized individuals, (b) Infected individuals. Parameter values used are
given in Tables 6 and 7. Blue lines correspond to non-IDUs, green represent the low-risk IDUs and red represent the high-risk IDUs
and sports teams, the transmission of MRSA is increased
due to increased physical contact and increased handling
of mutual fomites [40–43]. The dynamics between these
communities can be applied to injection drug users who
exhibit similar habits as those listed in Table 3.
In today’s IDU communities, the spread and conse-
quences of MRSA infections are of the greatest concern.
The resistant bacteria’s severely virulent nature and the
associated risk factors of IDU behaviors create an ideal
habitat for MRSA. Living in drug houses, sharing needles
or saliva are all routine practices for IDUs and all lead to
an increase in the risk ofMRSA infection [3]. For instance,
Cohen et al. [21] found that the use of methamphetamine
resulted in an increased number of MRSA skin and soft
tissue infections than in those who were not using the
drug. MRSA transmission is often times unknown due to
asymptomatic colonization [39]. This combined with the
increase in risky behaviors contributes to the increase in
infected individuals in both IDU subgroups. The known
and unique risks IDUs possess contribute to the high
infection rate of not only MRSA but well studied HIV
transmission [44, 45].
The National Survey on Drug Use and Health (NSDUH)
broadens their definition of a risk factor to also include
social and mental contributors such as the ideation of a
low risk of harm from illicit drug use and availability of
the drug [46]. In large metropolitan areas illicit drugs are
readily available and according to NSDUH 2015 survey,
over 1.5 million people in large metropolitan areas per-
ceived access to illicit drugs as being fairly or very easy
versus only 405,000 in non-metropolitan areas [36, 46].
Hence, it is imperative to reduce the risk factor acting on
individuals and improve protective factors or decreased
likelihood of substance abuse [36, 46]. And these, accord-
ing to NSDUH, should be the goals of any prevention
programs [46].
These are the goals that we aimed to achieve in this
study and the results obtained from the control strategies
implemented in ourmodel align well with these goals. Fur-
thermore, the results of our model numerical exploration
shows that as the risk factor increases, the number of
colonized and infected individuals increases as expected.
This increase is observed in all the three subgroups under
consideration.
Fig. 8MRSA model simulation with large metro demographics. Each simulation shows a restriction of individuals transition between sub-groups
with the parameter values ωN = 0,ωL = 0,αL = 0.0112,αH = 0.0560 (a) Colonized individuals, (b) Infected individuals. Parameter values used are as
given in Tables 6 and 7. Blue lines correspond to non-IDUs, green represent the low-risk IDUs and red represent the high-risk IDUs
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Fig. 9MRSA model simulation with large metro demographics. Each simulation shows a restriction of individuals transition between sub-groups
with the parameter values ωN = 0.05825,ωL = 0.116,αL = 0.0112,αH = 0.0560 (a) Colonized individuals, (b) Infected individuals. Parameter values
used are as given in Tables 6 and 7. Blue lines correspond to non-IDUs, green represent the low-risk IDUs and red represent the high-risk IDUs
In parameterizing our model we have used large metro,
large suburb, and rural areas data from the Agency for
Healthcare Research and Quality (see Table 2 and Fig. 3).
However, we have only used the results for the large
meteropolitan areas in our numerical explorations. MRSA
is also of concern in suburbs and rural areas due in part
to the presence of IDUs [47] and we clearly observed
this from the data. Furthermore, the NSDUH 2015 survey
found that lifetime use of illicit drugs in large and small
metropolitan areas was 113,967 while non-metropolitan
areas were 16,644. These statistics bring to light the
great need for action in drug abuse interventions in not
only metropolitan areas but also suburbs and rural areas.
In future work, we will study the impact of movement
between large metro, suburb and rural regional areas on
the transmission of MRSA among non-IDUs and both
low-and high-risk IDUs.
The Agency for Healthcare Research and Quality
reported a 21% reduction in hospital acquired condi-
tions (HAC) from 2010-2015 [48], this reduction includes
Fig. 10 Simulation of the MRSA model (1) with IDUs showing the various effectiveness control strategies for total number of infected in each of the
different subgroups: a Non-IDUs; b Low-risk IDUs; c High-risk IDUs. Parameter values used are as given in Tables 6 and 7. Blue lines correspond to
low-effectiveness strategy, turquoise blue represent moderate-effectiveness strategy and magenta represent the high-effectiveness strategy
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Table 8 Simulation of the MRSA model (1) with IDUs showing the various effectiveness control strategies for total number of infected
in each of the different subgroups at time t = 100
Cases Low-effective control Moderate-effective control High-effective control
Non-IDUs colonized cases 3.404526 × 105 1.285701 × 105 2.854360 × 104
Low-risk IDUs colonized cases 7.949563 × 105 3.411524 × 105 4.270152 × 104
High-risk IDUs colonized cases 1.025625 × 106 5.593364 × 105 6.303055 × 104
Non-IDUs infected cases 8.330656 × 105 3.404935 × 105 9.403137 × 104
Low-risk IDUs infected cases 3.582918 × 106 1.687638 × 106 2.544196 × 105
High-risk IDUs infected cases 1.007395 × 107 5.287627 × 106 7.160370 × 105
HA-MRSA. During this five-year period, there was a
3 million reduction in the number of cases and $28 billion
dollars saved in fighting HACs [48]. Unfortunately, this
same results cannot be said of CA-MRSA. To achieve sim-
ilar significant results as seen with HACs, more research
and community efforts will be needed. Nevertheless, these
results can be seen with a bright outlook for the future
prevention and treatment of MRSA in communities such
as IDUs.
Conclusions
In this section, we summarize some of the main theoreti-
cal and epidemiological findings of this study:
(i) The disease-free equilibrium of the model (1) is
locally-asymptotically stable whenever the associated
reproduction number (R0) is less than unity.
(ii) The model was parametrized by
(a) parameterizing the reduced non-IDUs model
(5) using AHRQ ICD-6 MRSA regional data
for large metro, suburb and rural areas;
(b) using risk factors obtained from a constructed
ethogram, the non-IDUs parameters are
projected onto low- and high-risk IDUs
related model parameters.
(iii) The sensitivity analysis of the parameter variations
using the associated reproduction number (RN ) as
response function of the reduced model (5) with
non-IDUs show the most dominant parameters are
the transmission probability (βN ) and the recovery
rate (γN ).
(iv) The effect of the risk factor was studied, and we
found as expected, that as the risk factor increases,
the number of colonized and infected increases.
(v) The study of the vertical downward and upward
transitions among non-IDUs and IDUs who are both
low-and high-risk users due to change in risky
behaviors shows an increase in MRSA cases in the
community as individual engage in these risky
behaviors. However, with more IDUs entering
rehabilitation programs (such as intervention,
education, and clean needle exchange programs)
MRSA cases reduces.
(vi) The horizontal translation within the subgroups due
to disease transmission was also studied by
implementing three different strategies:
low-effectiveness strategy, moderate-effectiveness
strategy, and high-effectiveness strategy. We found
that high-effectiveness control strategy is more
effective in curtailing MRSA burden in the
community; further, we found that the
moderate-effectiveness strategy is also an effective
control strategy.
Appendix A: Analysis of themodel
Basic qualitative properties
Positivity and boundedness of solutions
For the MRSA transmission model (1) with IDUs to be
epidemiologically meaningful, it is important to prove
that all its state variables are non-negative for all time.
In other words, solutions of the model system (1) with
non-negative initial data will remain non-negative for all
time t > 0.
Lemma 1 Let the initial data F(0) ≥ 0 , where
F(t) = (UN ,CN , IN ,UL,CL, IL,UH ,CH , IH). Then the solu-
tions F(t) of the MRSA model (1) with IDUs are non-






where πH = πN + πL + πH and
NH(t) = UN + CN + IN + UL + CL + IL + UH + CH + IH .
Proof Let t1 = sup{t > 0 : F(t) > 0 ∈[ 0, t] }. Thus,




= πN + αLUL + γNIN + τCN
− βN (CN + IN + CL + IL + CH + IH)
N
− (ωN + μ)UN
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Similarly, it can be shown that F > 0 for all t > 0.
For the second part of the proof, note that 0 < CN (t) ≤
N(t), 0 < IN (t) ≤ N(t), 0 < UL(t) ≤ N(t), 0 < CL(t) ≤
N(t), 0 < IL(t) ≤ N(t), 0 < UH(t) ≤ N(t), 0 < CH(t) ≤
N(t), 0 < IH(t) ≤ N(t).
Adding the human and mosquito component of the
MRSA model (1) with IDUs gives
dN(t)
dt
= πH − μN(t),










The MRSA model (1) with IDUs will be analyzed in a










Lemma 2 The region  ⊂ R9+ is positively-invariant for
the MRSA model (1) with IDUs with non-negative initial
conditions in R9+.




=  − μN − δNIN − δLIL − δHIH
≤  − μN




1 − e−μt). In particular, N(t) ≤ 
μ
.
Thus, the region  is positively-invariant. Furthermore,
if N(0) > 
μ
, then either the solutions enters  in finite
time, or N(t) approaches 
μ
asymptotically. Hence, the
region  attracts all solutions in R9+.
Appendix B: Stability of disease-free equilibrium
(DFE) and the basic reproduction numberR0
The conditions for stability of the equilibria of the model
(1) are stated in this section.
TheMRSAmodel (1) with IDUs has a disease-free equi-
librium (DFE), obtained by setting the right-hand sides of
the equations in the model to zero, given by
E0 =
(
U∗N ,C∗N , I∗N ,U∗L ,C∗L , I∗L ,U∗H ,C∗H , I∗H
)






) + αLπLg3 + αLαHπH
g1g2g3 − αHωLg1 − ωNαLg3 ,
U∗L =
πNωNg3 + πLg1g3 + αHπHg1
g1g2g3 − αHωLg1 − ωNαLg3 ,
U∗H =




g1g2g3 − αHωLg1 − ωNαLg3 ,
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withg1 = ωN + μ, g2 = ωL + αL + μ, g3 = αH + μ.
The linear stability of E0 can be established using the
next generation operator method on the system (1). Tak-
ing, CN , IN ,CL, IL,CH , IH , as the infected compartments,
then using the notation in [19], the Jacobian matrices F
and V for the new infection terms and the remaining

















































k2 0 −αL 0 0 0
−σN k3 0 −αL 0 0
−ωN 0 k5 0 −αH 0
0 −ωN −σL k6 0 −αH
0 0 −ωL 0 k7 0




where k1 = ωN +μ, k2 = τN +σN +ωN +μ, k3 = γN +
ωN + μ + δN , k4 = ωL + αL + μ, k5 = τL + ωL +
αL + σL + μ, k7 = αH + μ, k6 = ωL + αL + γL + μ +
δL, k8 = τH + αH + σH + μ, k9 = αH + γH + μ + δH .
It follows that the basic reproduction number of the




) = RN + RL + RH , (12)
where ρ is the spectral radius and
RN = βNU∗N [k7ωN (k3k8 + ωLk3 + k8αL)σL
+(k6k8 + ωNk8 + ωNωL − ωLαH)(k5k7 − ωLαH)σN
+ωNωL(k3k6 + k3αH + αHαL − ωNαL)σH
+(k5k7 + k7ωN + ωLωN − ωLαH)
×(k3k6k8 − k3ωLαH − k8ωNαL)]
/N∗(k3k6k8 − k3ωLαH − k8ωNαL)
×(k2k5k7 − k2ωLαH − k7ωNαL)
RL = βLU∗L [k2k7(k3k8 + ωLk3 + αLk8)σL
+k7αL(k6k8 + k8ωN + ωNωL − ωLαH)σN
+k2ωL(k3k6 + k3αH + αLαH − ωNαL)σH
+(k2k7 + k2ωL + k7αL)(k3k6k8 − k3ωLαH
−k8ωNαL)] /N∗(k3k6k8 − k3ωLαH − k8ωNαL)
×(k2k5k7 − k2ωLαH − k7ωNαL)
RH = βHU∗H [αLαH(k6k8 + k8ωN + ωNωL − ωLαH)σN
+k2αH(k3k8 + k3ωL + k8αL)σL
+(k3k6 + k3αH + αLαH − ωNαL)(k2k5 − ωNαL)σH
+(k2k5 + k2αH + αLαH − ωNαL)(k3k8k6 − k8ωNαL
−k3ωLαH)] /N∗(k3k6k8 − k3ωLαH − k8ωNαL)
×(k2k5k7 − k2ωLαH − k7ωNαL).
Furthermore, the expression RN is the number of sec-
ondary infections among the non-injection drug users,RL
is the number of secondary infections among the low-
risk injection drug users, RH is the number of secondary
infections among the high-risk injection drug users. These
expressions (RN ,RL,RH ) further show the secondary
infection in each sub-groups due to both horizontal and
vertical transition of infectious individuals. Hence, using
Theorem 2 in [19], the following result is established.
Lemma 3 The disease-free equilibrium (E0) of theMRSA
model (1) with IDUs is locally asymptotically stable (LAS)
ifR0 < 1 and unstable ifR0 > 1.
The basic reproduction number R0 is defined as the
average number of new infections that result from one
infectious individual in a population that is fully suscepti-
ble [16–19]. The epidemiological significance of Lemma 3
is that MRSA will be eliminated from the community if
the reproduction number (R0) can be brought to (and
maintained at) a value less than unity.
The basic reproduction number when
ωN = ωL = αL = αH = 0
Suppose the vertical upward and downward transition
between the subgroups are absent, that is, ωN = 0, ωL =
0, αL = 0, αH = 0, then the DFE (10) becomes


















k1 0 0 0 0 0
−σN k2 0 0 0 0
0 0 k3 0 0 0
0 0 −σL k4 0 0
0 0 0 0 k5 0
0 0 0 0 −σH k6
⎞
⎟⎟⎟⎟⎟⎟⎠
The basic reproduction number of the MRSA model (1)








N (k3 + σN )
k2k3N∗










It should be noted that the reproduction number stated
in Eq. (12) gives the reproduction number in Eq. (13) in
the absence of vertical downward and upward transition,
that is if ωN = ωL = αL = αH = 0.
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